Production (Stage)
Neural Therapeutics Inc.
NURL
CNSX
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -51.81% | 699.79% | -2.48% | 183.04% | -67.43% |
Total Receivables | 280.00% | -65.12% | 7.50% | 27.39% | 18.05% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 0.00% | 0.00% | -- | -- |
Total Current Assets | -40.88% | 452.22% | 0.58% | 112.54% | -50.23% |
|
|||||
Total Current Assets | -40.88% | 452.22% | 0.58% | 112.54% | -50.23% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -40.88% | 452.22% | 0.58% | 112.54% | -50.23% |
|
|||||
Total Accounts Payable | -41.99% | -38.81% | 71.59% | 22.91% | -41.12% |
Total Accrued Expenses | -33.74% | -28.13% | 20.11% | 112.80% | -63.10% |
Short-term Debt | -- | -1.20% | 2.47% | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -38.38% | -30.12% | 29.68% | 91.95% | -58.27% |
|
|||||
Total Current Liabilities | -38.38% | -30.12% | 29.68% | 91.95% | -58.27% |
Long-Term Debt | 9.17% | 82.13% | -0.85% | -0.48% | 160.50% |
Short-term Debt | -- | -1.20% | 2.47% | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -0.83% | 98.90% | -- |
Total Liabilities | -4.67% | 9.85% | 11.12% | 33.26% | 11.15% |
|
|||||
Common Stock & APIC | 24.67% | -2.31% | -0.87% | -0.50% | -2.66% |
Retained Earnings | -28.36% | 1.09% | -1.54% | -4.79% | -0.48% |
Treasury Stock & Other | 33.75% | 68.67% | 0.51% | 12.53% | -1.11% |
Total Common Equity | -41.44% | 45.63% | -12.63% | -26.66% | -23.91% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -41.44% | 45.63% | -12.63% | -26.66% | -23.91% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -41.44% | 45.63% | -12.63% | -26.66% | -23.91% |
|